Corbevex expected to get WHO prequalification, says Mahima Datla https://ift.tt/GiuK79S

Explaining that the COVID story is still not done, and there needs to be advanced preparations to be able to meet those exigencies, Mahima Datla, Managing Director, Biological E Ltd informed that they have asked and applied to the Drug Controller General of India (DCGI) to move the bivalent, specific vaccine through its clinical trial phase. Added that they are in talks with the government on primary immunisation for children below the age of 12, admission of Corbevex as a booster, and the vaccine's admissibility for children who have recently turned 12.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/UDTj4Vx